📋 Tender Overview
Personalised Blueprint Intestinal Health
Health-To-Inflammatory Bowel Disease Transitioninflammatory Bowel Disease (Ibd) Is Characterised By Chronic Inflammation In The Lining Of The Colon And The Small Intestine. Currently, There Are No Biomarkers For Predicting An Individual’S Risk To Develop Ibd. The Eu-Funded Migut-Health Project Proposes To Address This Unmet Need By Integrating Disease Models And Molecular And Clinical Data Alongside Novel Technologies. In Addition, Researchers Will Investigate The Impact Of Diet And The Gut Microbiome On Intestinal Inflammation. Collectively, The Project Will Help Understand How Healthy Individuals May Transition To Ibd Onset And Engage Patients In Self-Management Through Ehealth Solutions.
Funded Under
Health
Total Cost
€ 7 131 243,75
Eu Contribution
€ 7 126 243,75
Coordinated By
Universitatsklinikum Schleswig-Holstein
Germany
Start Date
1 January 2023
End Date
31 December 2026
